Recurrence After Posttreatment Plasma and Saliva HPV DNA Testing in Low-Risk HPV Oropharynx Cancer
This cohort study examines patients with low-risk human papillomavirus –positive oropharynx cancer at risk for recurrence by detection of HPV16 DNA in plasma and salivary rinses.
Source: JAMA Otolaryngology - Head and Neck Surgery - Category: ENT & OMF Source Type: research
More News: Cancer | Cancer & Oncology | ENT & OMF | Genital Warts | Head and Neck Cancer | HPV Testing | Human Papillomavirus (HPV) | Oropharyngeal Cancer | Study